The PAPAA Forum: Dr David Ashton

Sulfasalasine and Covid-19 infection Nov 4th 2022, 08.55

• Author: Dr David Ashton
• Topic: Coronavirus (COVID-19)

Sulfasalasine, a disease-modifying antirheumatic drug (DMARD), has a well-established role in the treatment of patients with chronic inflammatory diseases, such a rheumatoid arthritis, inflammatory bowel disease and psoriatic arthritis.  It is often used in patients who are unable to tolerate methotrexate. Sulfasalasine has anti-inflammatory,…

Update to COVID-19 FAQs Dec 6th 2021, 13.52

• Author: Dr David Ashton
• Topic:

COVID-19 remains a serious health risk. You should stay cautious to help protect yourself and others. The latest advice from the UK Government says:

• Let fresh air in if you meet indoors. Meeting outdoors is safer
• You must wear a face covering in shops and on all public transport (check local differences)
• Get tested and self-isolate, if…

Lung disease and psoriasis Jul 27th 2021, 13.50

• Author: Dr David Ashton
• Topic:

Introduction

One of the significant symptoms of Covid-19 is a persistent cough and, in severe cases, shortness of breath.  Whilst this is not the place to discuss the specific features or details of coronavirus infection, it’s a useful moment to review the various lung conditions associated with psoriasis and whether any of the current systemic…

Psoriasis patients more susceptible to COVID-19 May 17th 2021, 09.55

• Author: Dr David Ashton
• Topic: Coronavirus (COVID-19)

As the COVID-19 pandemic has continued, researchers have been able to study individual groups of patients with pre-existing medical conditions – including psoriasis.  One especially important question, is whether patients diagnosed with psoriasis, could be more at risk of infection with COVID-19?  

In a recent (virtual) meeting of the American…